
|Articles|April 4, 2016
Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
Author(s)DIA
Advertisement
Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
2
How Basket-Trials are Reshaping Drug Development Timelines
3
The New Capital of Care in Rare Disease
4
Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ
5




